ASX - Delayed Quote AUD
Zelira Therapeutics Limited (ZLD.AX)
At close: 3:30 PM GMT+11
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Cash Flows from Used in Operating Activities Direct
-4,388.5900
-4,388.5900
-7,249.0780
-9,427.2240
-8,616.5940
Investing Cash Flow
919.7350
919.7350
2,829.2350
-207.7820
1,378.3490
Financing Cash Flow
3,924.0340
3,924.0340
1,770.0390
7,099.5940
10,531.3160
End Cash Position
586.1610
586.1610
146.2060
2,746.4090
4,971.1160
Interest Paid Supplemental Data
38.5080
38.5080
26.5710
--
--
Issuance of Capital Stock
--
--
1,770.0390
7,099.5940
10,619.3160
Issuance of Debt
3,924.0340
3,924.0340
--
--
--
Repurchase of Capital Stock
-286.7020
--
--
--
-88.0000
Free Cash Flow
-4,388.5900
-4,388.5900
-7,249.0780
-9,427.2240
-8,616.5940
6/30/2021 - 7/25/2003
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
PAB.AX Patrys Limited
0.0040
+33.33%
TRP.AX Tissue Repair Ltd
0.2650
-3.64%
NYR.AX Nyrada Inc.
0.1100
+4.76%
VBS.AX Vectus Biosystems Limited
0.0800
0.00%
NSB.AX NeuroScientific Biopharmaceuticals Limited
0.0380
0.00%
PTX.AX Prescient Therapeutics Limited
0.0410
-4.65%
PIQ.AX Proteomics International Laboratories Ltd
0.7000
+1.45%
RAD.AX Radiopharm Theranostics Limited
0.0240
+4.35%
NOX.AX Noxopharm Limited
0.1100
+4.76%
PYC.AX PYC Therapeutics Limited
0.2000
+5.26%